撤回：VGLL4通过激活Hippo-YAP/TEAD1信号通路保护内皮细胞免受氧化型低密度脂蛋白诱导的功能障碍和炎症。
Retracted: VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.
作者信息
Of Inflammation Mediators
出版信息
Mediators Inflamm. 2022 Apr 28;2022:9851919. doi: 10.1155/2022/9851919. eCollection 2022.
Abstract
[This retracts the article DOI: 10.1155/2020/8292173.].
摘要
[本文撤回文章DOI: 10.1155/2020/8292173。]
相似文献
1
Retracted: VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.撤回：VGLL4通过激活Hippo-YAP/TEAD1信号通路保护内皮细胞免受氧化型低密度脂蛋白诱导的功能障碍和炎症。
Mediators Inflamm. 2022 Apr 28;2022:9851919. doi: 10.1155/2022/9851919. eCollection 2022.
2
VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.VGLL4 通过激活 Hippo-YAP/TEAD1 信号通路来保护血管内皮细胞免受氧化型 LDL 诱导的功能障碍和炎症反应。
Mediators Inflamm. 2020 Dec 29;2020:8292173. doi: 10.1155/2020/8292173. eCollection 2020.
3
Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.VGLL4的乙酰化调控Hippo-YAP信号通路及出生后心脏生长。
Dev Cell. 2016 Nov 21;39(4):466-479. doi: 10.1016/j.devcel.2016.09.005. Epub 2016 Oct 6.
4
miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.微小RNA-222/VGLL4/YAP-TEAD1调控环促进胃癌细胞的增殖和侵袭。
Am J Cancer Res. 2015 Feb 15;5(3):1158-68. eCollection 2015.
5
Oxidized low-density lipoprotein promotes vascular endothelial cell dysfunction by stimulating miR-496 expression and inhibiting the Hippo pathway effector YAP.氧化型低密度脂蛋白通过刺激 miR-496 的表达和抑制 Hippo 通路效应物 YAP 促进血管内皮细胞功能障碍。
Cell Biol Int. 2019 May;43(5):528-538. doi: 10.1002/cbin.11120. Epub 2019 Mar 19.
6
Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.Hippo 信号缺失导致压力超负荷时心肌细胞去分化伴随的心脏功能障碍。
Circ Res. 2019 Jan 18;124(2):292-305. doi: 10.1161/CIRCRESAHA.118.314048.
7
Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity.细胞周期蛋白依赖性激酶1（CDK1）介导的转录共抑制因子Vgll4的有丝分裂磷酸化抑制了其肿瘤抑制活性。
J Biol Chem. 2017 Sep 8;292(36):15028-15038. doi: 10.1074/jbc.M117.796284. Epub 2017 Jul 24.
8
The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex.TEA 结构域家族转录因子 TEAD4 通过招募共因子 VGLL4 和 CtBP2 进入转录复合物来抑制小鼠脂肪生成。
J Biol Chem. 2018 Nov 2;293(44):17119-17134. doi: 10.1074/jbc.RA118.003608. Epub 2018 Sep 12.
9
VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.VGLL4是一种转录辅因子，通过与TEADs相互作用发挥新型肿瘤抑制因子的作用。
Am J Cancer Res. 2018 Jun 1;8(6):932-943. eCollection 2018.
10
VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer.VGLL4 与低表达的 YAP 与结直肠癌的良好预后相关。
APMIS. 2020 Oct;128(10):543-551. doi: 10.1111/apm.13070. Epub 2020 Sep 14.
本文引用的文献
1
VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.VGLL4 通过激活 Hippo-YAP/TEAD1 信号通路来保护血管内皮细胞免受氧化型 LDL 诱导的功能障碍和炎症反应。
Mediators Inflamm. 2020 Dec 29;2020:8292173. doi: 10.1155/2020/8292173. eCollection 2020.
Zotero 插件